ELabNYC announced the 7th cohort of emerging biosciences ventures invited to participate in its competitive annual business accelerator program on December 21, 2018. Out of the 20 high-potential companies selected, three have strong Columbia Business School ties.
Laurence Coman ’20, Joongheum Park,Yair Saperstein (Columbia University/ SUNY Downstate): AvoMD’s modules curate highly relevant clinical knowledge using conversational user interface carefully designed for clinical providers, mimicking consultations with clinical specialists.
Seth Goodman ’19 (Columbia University): SiteRx is the first virtual clinical trial site focused on building the bridge between clinical research and clinical care.
Rotem Lev-Zwickel ’18: Agamon partners with hospitals, structures their textual clinical data using natural language processing and provides tools and services for a faster, efficient and scalable way to access clinical data and insights.
ELabNYC, the Entrepreneurship Lab NYC, is a prestigious six-month training and mentorship program for aspiring entrepreneurs in New York City’s life sciences and healthcare technology community. It provides extensive support and training to graduate students of science, post-docs, early-career researchers and engineers interested in forming new biotech and health tech ventures. They participate in the six-month intensive program, which includes business education to develop fundable business plans and support from a professional mentoring and alumni network. All startups receive an entrepreneur coach, access to active business professionals and preparation support to pitch to investors.
The selected startups were chosen via an extensive screening and interview process. An elite advisory team, consisting of leading scientists, active investors and business strategists, evaluated this class of ventures based on metrics such as strength of the team, uniqueness of insights into the problems they are solving and their capacity to revolutionize the life sciences industry.